Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
12 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250811862394/en/Marea-Therapeutics-Enrolls-First-Participant-in-Phase-1-Clinical-Study-Evaluating-MAR002-for-Acromegaly
04 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250803630698/en/Marea-Therapeutics-Enrolls-First-Patient-in-Phase-2b-TYDAL-TIMI-78-Clinical-Study-Evaluating-MAR001-in-Adults-at-Risk-of-ASCVD
14 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250713923670/en/Marea-Therapeutics-Presents-Preclinical-Data-on-Novel-Growth-Hormone-Receptor-Antagonist-Antibody-MAR002-for-the-Treatment-of-Acromegaly-at-ENDO-2025
01 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250630861477/en/Marea-Therapeutics-Appoints-Shishir-Gadam-Ph.D.-as-Chief-Technical-Officer
24 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250623891703/en/Marea-Therapeutics-Announces-Oral-Presentation-Related-to-Acromegaly-Program-at-ENDO-2025
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250519952961/en/Marea-Therapeutics-Appoints-Charmi-Turner-as-Senior-Vice-President-People-Culture
ABOUT THIS PAGE
Marea Therapeutics is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Flunixin Meglumine bulk with CEP offered by Marea Therapeutics
Find a price of Ceftiofur bulk offered by Marea Therapeutics
Find a price of Cephapirin Benzathine bulk offered by Marea Therapeutics
Find a price of Cephapirin Sodium bulk offered by Marea Therapeutics
Find a price of Gamithromycin bulk offered by Marea Therapeutics
Find a price of Nicarbazin bulk offered by Marea Therapeutics
Find a price of Tilmicosin Phosphate bulk offered by Marea Therapeutics